Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06977386

The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer

Spectral CT was used to prospectively collect medical images and clinical data related to gastric cancer, evaluate the effect of image quality in the diagnosis of gastric cancer, and evaluate the application value in the accurate staging of gastric cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Gastric Cancer Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Neoplasms Neoplasms by Site Stomach Diseases Stomach Neoplasms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • (a)Patients with pathologically confirmed gastric cancer;
  • (b) aged ≥ 18 years old;
  • (c) have not received chemoradiotherapy or surgery.

Exclusion criteria

  • (a)Combined with other primary tumors;
  • (b) The image quality does not meet the diagnostic criteria;
  • (c)Those who cannot tolerate CT examination.

Treatment and study plan

To explore the value of spectral CT in the diagnosis and treatment of gastric cancer

Diagnostic Test

CT scan of the abdomen outside of standard treatment options

Primary outcomes

  1. Pathological TNM staging

    Time frame: 1 day

    Pathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded

Study contacts

Contact information is provided by the study sponsor or research team.

Ruiling Yang

CONTACT

[email protected]

17390212095

zhenhui Li

CONTACT

[email protected]

13698736132

Sponsors and collaborators

Lead sponsor

Yunnan Cancer Hospital

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
May 18, 2025
Registry last updated
May 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.